What is Medicina?
Medicina is a prominent provider of ENFit enteral delivery systems, offering a comprehensive suite of products designed to enhance safety and efficiency in enteral access. Their product line includes ENFit syringes, nasogastric feeding tubes, and associated accessories, catering to both adult and neonatal patient needs. The company places a strong emphasis on neonatal care, aiming to equip healthcare providers with innovative medical devices that improve patient outcomes. Medicina distributes its specialized medical equipment across the UK and select European markets, serving hospitals and health organizations globally.
How much funding has Medicina raised?
Medicina has raised a total of $9.8M across 1 funding round:
Unspecified
$9.8M
Unspecified (2013): $9.8M with participation from Business Growth Fund
Key Investors in Medicina
Business Growth Fund
Business Growth Fund (BGF) is a leading investor in UK small and mid-sized businesses, known for its active support across various economic sectors. They provide growth capital to companies at different stages of development.
What's next for Medicina?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for Medicina. This capital infusion is expected to fuel further expansion of their distribution network within the UK and Europe, potentially enabling deeper penetration into new international markets. The company is likely to leverage this financial backing to accelerate product development, enhance manufacturing capabilities, and bolster its market presence in the competitive medical device industry, particularly within the critical neonatal care segment.
See full Medicina company page
